EGFR and non-small cell lung carcinoma: Testing using the OncoBEAMTM‐EGFR assay enabled detection of the p.T790M EGFR mutation in 40/183 NSCLC patients (21.8%) versus 20/183 (10.9%), using the NGS assay.